Skip to main content

العربية

Search

VISIT JANSSEN GLOBAL

News Press Releases

Feb 21, 2014

Beerse, Belgium

VOKANAMET (canagliflozin and metformin fixed dose combination) receives positive CHMP opinion recommending approval in the European Union for the treatment of adults with type 2 diabetes

Jan 22, 2014

Beerse, Belgium

Janssen Announces New Group Targeting Unmet Global Health Needs

Jan 20, 2014

New Brunswick, NJ

Johnson & Johnson Announces Clinical Trial Data Sharing Agreement with Yale School of Medicine

Jan 07, 2014

Beerse, Belgium

Independent Data Monitoring Committee Recommends Early Stopping of Phase 3 Study of Ibrutinib in Relapsed/Refractory CLL/SLL Patients Based on a Planned Interim Analysis

Nov 22, 2013

Beerse, Belgium

Invokana (canagliflozin) EC approval

Nov 01, 2013

Beerse, Belgium

27 Incivo^® (Telaprevir) Data To Be Presented At Aasld And Ispor, Two Major International Congresses, On The Anti-Viral Response, Safety, Tolerability And Cost-Effectiveness Of An Incivo^®(Telaprevir) Based Regimen In The Treatment Of Genotype-1 Chronic Hepatitis C

Oct 29, 2013

Beerse, Belgium

Stop Hiding, Take Action! / World Psoriasis Day 2013 press release

Oct 16, 2013

Beerse, Belgium

Survey on knowledge of liver cancer and viral hepatitis

Oct 16, 2013

Beerse, Belgium

Multicountry Survey Results Highlighting Limited Knowledge Of Viral Hepatitis And Liver Cancer Reinforces Need For Action

Oct 15, 2013

Beerse, Belgium

Janssen Submits Marketing Authorisation Application to European Medicines Agency for a Fixed-Dose Combination Tablet of HIV-1 Medicine Darunavir with Cobicistat